Multimodal Imaging of Integrin Receptor-Positive Tumors by Bioluminescence, Fluorescence, Gamma Scintigraphy, and Single-Photon Emission Computed Tomography Using a Cyclic RGD Peptide Labeled with a Near-Infrared Fluorescent Dye and a Radionuclide

Integrins, particularly the α v β 3 heterodimers, play important roles in tumor-induced angiogenesis and invasiveness. To image the expression pattern of the α v β 3 integrin in tumors through a multimodality imaging paradigm, we prepared a cyclic RGDyK peptide analogue (LS308) bearing a tetraazamac...

Full description

Bibliographic Details
Main Authors: W. Barry Edwards, Walter J. Akers, Yunpeng Ye, Philip P. Cheney, Sharon Bloch, Baogang Xu, Richard Laforest, Samuel Achilefu
Format: Article
Language:English
Published: SAGE Publications 2009-03-01
Series:Molecular Imaging
Online Access:https://doi.org/10.2310/7290.2009.00014
_version_ 1797288121726926848
author W. Barry Edwards
Walter J. Akers
Yunpeng Ye
Philip P. Cheney
Sharon Bloch
Baogang Xu
Richard Laforest
Samuel Achilefu
author_facet W. Barry Edwards
Walter J. Akers
Yunpeng Ye
Philip P. Cheney
Sharon Bloch
Baogang Xu
Richard Laforest
Samuel Achilefu
author_sort W. Barry Edwards
collection DOAJ
description Integrins, particularly the α v β 3 heterodimers, play important roles in tumor-induced angiogenesis and invasiveness. To image the expression pattern of the α v β 3 integrin in tumors through a multimodality imaging paradigm, we prepared a cyclic RGDyK peptide analogue (LS308) bearing a tetraazamacrocycle 1,4,7,10-tetraazacyclododecane- N, N′, N″, N‴ -tetraacetic acid (DOTA) and a lipophilic near-infrared (NIR) fluorescent dye cypate. The α v β 3 integrin binding affinity and the internalization properties of LS308 mediated by the α v β 3 integrin in 4t1 luc cells were investigated by receptor binding assay and fluorescence microscopy, respectively. The in vivo distribution of 111 In-labeled LS308 in a 4t1 luc tumor-bearing mouse model was studied by fluorescence, bioluminescence, planar gamma, and single-photon emission computed tomography (SPECT). The results show that LS308 has high affinity for α v β 3 integrin and internalized preferentially via the α v β 3 integrin-mediated endocytosis in 4t1 luc cells. We also found that LS308 selectively accumulated in α v β 3 -positve tumors in a receptor-specific manner and was visualized by the four imaging methods. Whereas the endogenous bioluminescence imaging identified the ensemble of the tumor tissue, the fluorescence and SPECT methods with the exogenous contrast agent LS308 reported the local expression of α v β 3 integrin. Thus, the multimodal imaging approach could provide important complementary diagnostic information for monitoring the efficacy of new antiangiogenic drugs.
first_indexed 2024-03-07T18:44:43Z
format Article
id doaj.art-b34da44a26ea4b85a54ef91a7c3cb795
institution Directory Open Access Journal
issn 1536-0121
language English
last_indexed 2024-03-07T18:44:43Z
publishDate 2009-03-01
publisher SAGE Publications
record_format Article
series Molecular Imaging
spelling doaj.art-b34da44a26ea4b85a54ef91a7c3cb7952024-03-02T03:06:58ZengSAGE PublicationsMolecular Imaging1536-01212009-03-01810.2310/7290.2009.0001410.2310_7290.2009.00014Multimodal Imaging of Integrin Receptor-Positive Tumors by Bioluminescence, Fluorescence, Gamma Scintigraphy, and Single-Photon Emission Computed Tomography Using a Cyclic RGD Peptide Labeled with a Near-Infrared Fluorescent Dye and a RadionuclideW. Barry EdwardsWalter J. AkersYunpeng YePhilip P. CheneySharon BlochBaogang XuRichard LaforestSamuel AchilefuIntegrins, particularly the α v β 3 heterodimers, play important roles in tumor-induced angiogenesis and invasiveness. To image the expression pattern of the α v β 3 integrin in tumors through a multimodality imaging paradigm, we prepared a cyclic RGDyK peptide analogue (LS308) bearing a tetraazamacrocycle 1,4,7,10-tetraazacyclododecane- N, N′, N″, N‴ -tetraacetic acid (DOTA) and a lipophilic near-infrared (NIR) fluorescent dye cypate. The α v β 3 integrin binding affinity and the internalization properties of LS308 mediated by the α v β 3 integrin in 4t1 luc cells were investigated by receptor binding assay and fluorescence microscopy, respectively. The in vivo distribution of 111 In-labeled LS308 in a 4t1 luc tumor-bearing mouse model was studied by fluorescence, bioluminescence, planar gamma, and single-photon emission computed tomography (SPECT). The results show that LS308 has high affinity for α v β 3 integrin and internalized preferentially via the α v β 3 integrin-mediated endocytosis in 4t1 luc cells. We also found that LS308 selectively accumulated in α v β 3 -positve tumors in a receptor-specific manner and was visualized by the four imaging methods. Whereas the endogenous bioluminescence imaging identified the ensemble of the tumor tissue, the fluorescence and SPECT methods with the exogenous contrast agent LS308 reported the local expression of α v β 3 integrin. Thus, the multimodal imaging approach could provide important complementary diagnostic information for monitoring the efficacy of new antiangiogenic drugs.https://doi.org/10.2310/7290.2009.00014
spellingShingle W. Barry Edwards
Walter J. Akers
Yunpeng Ye
Philip P. Cheney
Sharon Bloch
Baogang Xu
Richard Laforest
Samuel Achilefu
Multimodal Imaging of Integrin Receptor-Positive Tumors by Bioluminescence, Fluorescence, Gamma Scintigraphy, and Single-Photon Emission Computed Tomography Using a Cyclic RGD Peptide Labeled with a Near-Infrared Fluorescent Dye and a Radionuclide
Molecular Imaging
title Multimodal Imaging of Integrin Receptor-Positive Tumors by Bioluminescence, Fluorescence, Gamma Scintigraphy, and Single-Photon Emission Computed Tomography Using a Cyclic RGD Peptide Labeled with a Near-Infrared Fluorescent Dye and a Radionuclide
title_full Multimodal Imaging of Integrin Receptor-Positive Tumors by Bioluminescence, Fluorescence, Gamma Scintigraphy, and Single-Photon Emission Computed Tomography Using a Cyclic RGD Peptide Labeled with a Near-Infrared Fluorescent Dye and a Radionuclide
title_fullStr Multimodal Imaging of Integrin Receptor-Positive Tumors by Bioluminescence, Fluorescence, Gamma Scintigraphy, and Single-Photon Emission Computed Tomography Using a Cyclic RGD Peptide Labeled with a Near-Infrared Fluorescent Dye and a Radionuclide
title_full_unstemmed Multimodal Imaging of Integrin Receptor-Positive Tumors by Bioluminescence, Fluorescence, Gamma Scintigraphy, and Single-Photon Emission Computed Tomography Using a Cyclic RGD Peptide Labeled with a Near-Infrared Fluorescent Dye and a Radionuclide
title_short Multimodal Imaging of Integrin Receptor-Positive Tumors by Bioluminescence, Fluorescence, Gamma Scintigraphy, and Single-Photon Emission Computed Tomography Using a Cyclic RGD Peptide Labeled with a Near-Infrared Fluorescent Dye and a Radionuclide
title_sort multimodal imaging of integrin receptor positive tumors by bioluminescence fluorescence gamma scintigraphy and single photon emission computed tomography using a cyclic rgd peptide labeled with a near infrared fluorescent dye and a radionuclide
url https://doi.org/10.2310/7290.2009.00014
work_keys_str_mv AT wbarryedwards multimodalimagingofintegrinreceptorpositivetumorsbybioluminescencefluorescencegammascintigraphyandsinglephotonemissioncomputedtomographyusingacyclicrgdpeptidelabeledwithanearinfraredfluorescentdyeandaradionuclide
AT walterjakers multimodalimagingofintegrinreceptorpositivetumorsbybioluminescencefluorescencegammascintigraphyandsinglephotonemissioncomputedtomographyusingacyclicrgdpeptidelabeledwithanearinfraredfluorescentdyeandaradionuclide
AT yunpengye multimodalimagingofintegrinreceptorpositivetumorsbybioluminescencefluorescencegammascintigraphyandsinglephotonemissioncomputedtomographyusingacyclicrgdpeptidelabeledwithanearinfraredfluorescentdyeandaradionuclide
AT philippcheney multimodalimagingofintegrinreceptorpositivetumorsbybioluminescencefluorescencegammascintigraphyandsinglephotonemissioncomputedtomographyusingacyclicrgdpeptidelabeledwithanearinfraredfluorescentdyeandaradionuclide
AT sharonbloch multimodalimagingofintegrinreceptorpositivetumorsbybioluminescencefluorescencegammascintigraphyandsinglephotonemissioncomputedtomographyusingacyclicrgdpeptidelabeledwithanearinfraredfluorescentdyeandaradionuclide
AT baogangxu multimodalimagingofintegrinreceptorpositivetumorsbybioluminescencefluorescencegammascintigraphyandsinglephotonemissioncomputedtomographyusingacyclicrgdpeptidelabeledwithanearinfraredfluorescentdyeandaradionuclide
AT richardlaforest multimodalimagingofintegrinreceptorpositivetumorsbybioluminescencefluorescencegammascintigraphyandsinglephotonemissioncomputedtomographyusingacyclicrgdpeptidelabeledwithanearinfraredfluorescentdyeandaradionuclide
AT samuelachilefu multimodalimagingofintegrinreceptorpositivetumorsbybioluminescencefluorescencegammascintigraphyandsinglephotonemissioncomputedtomographyusingacyclicrgdpeptidelabeledwithanearinfraredfluorescentdyeandaradionuclide